A New Era in Life Science is Here | April 1, 2022

The Breakthrough Innovation Forum

Jumbotron_BIF

What do you get when you combine the best ideas coming out of biology, chemistry and data science?

 

A powerful tool with the potential to change lives for the better.

 

From curing incurable diseases, providing people with preventive tools to live healthier, better and longer lives, to producing enough food for our growing population without starving the planet, we are on the brink of unlocking a world of enormous potential. 

 

While the world’s biggest challenges may appear to be very different in nature, the key to overcoming them could be similar. It all comes down to this confluence of the life sciences and data science.

 

Join us for the Bayer Breakthrough Innovation Forum where we will shed light on the promise this new era in the Life Sciences holds for humanity.

BIF
Breakthrough Innovation Forum
1:55
00:00
Speakers
Werner Baumann
Werner Baumann
CEO of Bayer AG

 

 

A new age of innovation in the Life Sciences

 

Jamie Metzl
Jamie Metzl
Technology Futurist and Author of Hacking Darwin: Genetic Engineering and the Future of Humanity

 

The perspective of a futurist 

 

Sarena Lin
Sarena Lin
Chief Transformation & Talent Officer and Member of the Board of Management of Bayer AG

 

Embracing the opportunities ahead of us – Bayer's transformation

 

Marianne De Backer
Marianne De Backer
Chief Business Officer, Bayer Pharmaceuticals division

 

Collaborating to innovate – The power of partnerships

 

Stefan Oelrich
Stefan Oelrich
Member of the Board of Management of Bayer AG and President of Bayer’s Pharmaceuticals division

 

The promise of new treatments powered by new technologies

 

Christian Rommel
Christian Rommel
Head of Research and Development, Bayer Pharmaceuticals division

 

Transforming the lives of patients by leveraging scientific innovation to address previously intractable diseases

 

jeff hatfield
Jeff Hatfield
Chief Executive Officer, Vividion Therapeutics

 

 

Seth Ettenberg
Seth Ettenberg
President and CEO, BlueRock Therapeutics

 

 

Jude Samulski
Jude Samulski
President, Chief Scientific Officer and Co-Founder, AskBio

 

 

Heiko Schipper
Heiko Schipper
Member of the Board of Management of Bayer AG and President of Bayer’s Consumer Health division

 

How data and new technologies bring preventative care to a new level

 

Rodrigo Santos
Rodrigo Santos
Member of the Board of Management of Bayer AG and President of Bayer’s Crop Science division

 

Transforming Agriculture for the benefit of farmers, society, and the planet

 

Bob Reiter
Robert Reiter
Head of Research and Development, Bayer Crop Science division

 

Creating a more sustainable food system with breakthrough innovations

 

rachel rama
Rachel Rama
Head of Small Molecules, Bayer Crop Science division

 

Creating a more sustainable food system with breakthrough innovations

 

john dombroski
John Dombrosky
Chief Executive Officer, Oerth bio

 

 

Creating a more sustainable food system with breakthrough innovations

 

Jürg Eckhardt
Jürg Eckhardt
Head of Leaps by Bayer

 

 

Addressing humanity’s biggest challenges: How Leaps by Bayer is venturing into a new realm of the Life Sciences

 

Nabiha Saklayen
Nabiha Saklayen
Co-Founder & CEO Cellino

 

 

Gonzalo Fuenzalida
Gonzalo Fuenzalida
Co-Founder & CEO Andes

 

 

Anat Binur
Anat Binur
Co-Founder & CEO Ukko

 

 

 

What does this mean for health and nutrition?

While still in its early stages,  the convergence of chemistry, biology and data science to accelerate innovation is much more than a theoretical scientific concept. Scientists around the world are already working on applications that leverage today’s enhanced technological toolkit to decode and engineer biology for the benefit of people and the planet.  

 

We are driven to push the limits of what medicine can do today. Cell and gene therapies can move the needle from managing sick care, to providing true healthcare. Precise, personalized care could one day be available to everyone on the planet — before they get sick.   

 

In agriculture, biotechnology will be a critical enabler for our ability to feed the 10 billion people that will be on the planet by 2050 while at the same time fighting the impact of climate change. To grow more food with fewer resources like water, we will need to shift to a regenerative approach and make crops more resilient to climate impacts. 

 

Shorter stature corn, and the number of resources it saves by not snapping in high winds, is just one example of climate-smart agriculture already in action. And advances in digital farming are giving growers the opportunity to maximize the amount of carbon they capture from the atmosphere. Our work to establish the carbon marketplace is one more example of genetics and data coming together to help solve what previously seemed unsolvable.

Health and nutrition are among the most basic needs of societies around the globe. It’s the definition of systemic relevance. Based on the converging worlds of genes, cells and data, we see a new foundation for scientific breakthroughs in those areas.
Werner Baumann
,
Chairman of the Board of Management (CEO) of Bayer AG